Diagnostic and prognostic role of cardiac magnetic resonance in acute myocarditis

被引:0
作者
Chrysanthos Grigoratos
Gianluca Di Bella
Giovanni Donato Aquaro
机构
[1] Fondazione Gabriele Monasterio CNR/Regione Toscana,Institute of Life Sciences
[2] Scuola Superiore Sant’Anna,Clinical and Experimental Department of Medicine and Pharmacology
[3] University of Messina,undefined
来源
Heart Failure Reviews | 2019年 / 24卷
关键词
Myocarditis; Cardiac magnetic resonance; Myocardial oedema; Myocardial fibrosis; Late gadolinium enhancement; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
Acute myocarditis (AM) is commonly found in everyday clinical practice. Differential diagnosis between various causes of myocardial damage with non-obstructive coronary arteries can be cumbersome for clinician. Moreover, AM may be provoked by a number of different causes and clinical presentation can be heterogeneous with potential overlap going from asymptomatic or subclinical to severe heart failure, arrhythmias, and death. Cardiac magnetic resonance (CMR) over the last decades has proven to be the diagnostic technique of choice since it allows identifying AM with excellent diagnostic accuracy. Latest technological advancement with parametric imaging such as T1 and T2 mapping further increases sensitivity and provides additional help towards a correct diagnosis. CMR however is no longer to be considered as a mere diagnostic tool but also as a powerful source of prognostic information. Scientific evidence has corroborated CMR’s role beyond diagnosis demonstrating how late gadolinium enhancement (LGE) presence is a powerful predictor of cardiac events and how the presence of septal LGE is to be considered of worst prognosis regardless of LGE extension even in patients with preserved global systolic function. CMR should be routinely performed in all patients with AM suspicion since its diagnostic and prognostic role is of paramount important and could modify therapeutic strategy and subsequent clinical decisions.
引用
收藏
页码:81 / 90
页数:9
相关论文
共 1072 条
[1]  
Richardson P(1996)Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies Circulation 93 841-842
[2]  
McKenna W(1957)Uncommon myocardial diseases. The non-coronary cardiomyopathies Lancet 270 1179-1184
[3]  
Bristow M(2015)Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013 Lancet 386 743-800
[4]  
Maisch B(2012)Medical progress: myocarditis N Engl J Med 360 1526-1538
[5]  
Mautner B(2012)Update on myocarditis J Am Coll Cardiol 59 779-792
[6]  
O'Connell J(2017)Myocarditis: a clinical overview Curr Cardiol Rep 19 63-63
[7]  
Olsen E(2004)Myocarditis susceptibility in female mice depends upon ovarian cycle phase at infection Virology 330 16-23
[8]  
Thiene G(2014)Chemotherapy-related cardiomyopathy in acute myeloid leukaemia assessed by cardiovascular magnetic resonance imaging Eur Heart J Cardiovasc Imaging 15 1410-1410
[9]  
Goodwin J(2009)Viral causes of human myocarditis Arch Cardiovasc Dis 102 559-568
[10]  
Gyarfas I(2003)Dissecting mechanisms of innate and acquired immunity in myocarditis Curr Opin Cardiol 18 175-181